134 related articles for article (PubMed ID: 35881946)
1. Recombinant human chorionic gonadotropin induces signaling pathways towards cancer prevention in the breast of BRCA1/2 mutation carriers.
Su Y; Dang NM; Depypere H; Santucci-Pereira J; Gutiérrez-Díez PJ; Kanefsky J; Janssens JP; Russo J
Eur J Cancer Prev; 2023 Mar; 32(2):126-138. PubMed ID: 35881946
[TBL] [Abstract][Full Text] [Related]
2. β-hCG-induced mutant BRCA1 ignites drug resistance in susceptible breast tissue.
Sengodan SK; Hemalatha SK; Nadhan R; Somanathan T; Mathew AP; Chil A; Kopczynski J; Nair RS; Kumar JM; Srinivas P
Carcinogenesis; 2019 Nov; 40(11):1415-1426. PubMed ID: 30963174
[TBL] [Abstract][Full Text] [Related]
3. Can we prevent BRCA1-associated breast cancer by RANKL inhibition?
Kotsopoulos J; Singer C; Narod SA
Breast Cancer Res Treat; 2017 Jan; 161(1):11-16. PubMed ID: 27783278
[TBL] [Abstract][Full Text] [Related]
4. Prolonged recombinant pregnancy hormone use in BRCA1 and BRCA2 mutation carriers.
Depypere H; Su Y; Dang N; Poppe B; Stanczyk F; Janssens J; Russo J
Eur J Cancer Prev; 2021 May; 30(3):195-203. PubMed ID: 33720054
[TBL] [Abstract][Full Text] [Related]
5. RANK ligand as a potential target for breast cancer prevention in BRCA1-mutation carriers.
Nolan E; Vaillant F; Branstetter D; Pal B; Giner G; Whitehead L; Lok SW; Mann GB; ; Rohrbach K; Huang LY; Soriano R; Smyth GK; Dougall WC; Visvader JE; Lindeman GJ
Nat Med; 2016 Aug; 22(8):933-9. PubMed ID: 27322743
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil.
Carraro DM; Koike Folgueira MA; Garcia Lisboa BC; Ribeiro Olivieri EH; Vitorino Krepischi AC; de Carvalho AF; de Carvalho Mota LD; Puga RD; do Socorro Maciel M; Michelli RA; de Lyra EC; Grosso SH; Soares FA; Achatz MI; Brentani H; Moreira-Filho CA; Brentani MM
PLoS One; 2013; 8(3):e57581. PubMed ID: 23469205
[TBL] [Abstract][Full Text] [Related]
7. Spatial Transcriptomics Suggests That Alterations Occur in the Preneoplastic Breast Microenvironment of BRCA1/2 Mutation Carriers.
Caputo A; Vipparthi K; Bazeley P; Downs-Kelly E; McIntire P; Duckworth LA; Ni Y; Hu B; Keri RA; Karaayvaz M
Mol Cancer Res; 2024 Feb; 22(2):169-180. PubMed ID: 37878345
[TBL] [Abstract][Full Text] [Related]
8. NF-κB at the Crossroads of Normal Mammary Gland Biology and the Pathogenesis and Prevention of
Sau A; Cabrita MA; Pratt MAC
Cancer Prev Res (Phila); 2018 Feb; 11(2):69-80. PubMed ID: 29101208
[TBL] [Abstract][Full Text] [Related]
9. Hormonal approach to breast cancer prevention.
Russo IH; Russo J
J Cell Biochem Suppl; 2000; 34():1-6. PubMed ID: 10762007
[TBL] [Abstract][Full Text] [Related]
10. Proteomic Profiling of β-hCG-Induced Spheres in BRCA1 Defective Triple Negative Breast Cancer Cells.
Sengodan SK; Rajan A; Hemalatha SK; Nadhan R; Jaleel A; Srinivas P
J Proteome Res; 2018 Jan; 17(1):276-289. PubMed ID: 29028349
[TBL] [Abstract][Full Text] [Related]
11. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
[TBL] [Abstract][Full Text] [Related]
12. Human Chorionic Gonadotropin and Breast Cancer.
Schüler-Toprak S; Treeck O; Ortmann O
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28754015
[TBL] [Abstract][Full Text] [Related]
13. Dissecting the heterogeneity and tumorigenesis of BRCA1 deficient mammary tumors via single cell RNA sequencing.
Sun H; Zeng J; Miao Z; Lei KC; Huang C; Hu L; Su SM; Chan UI; Miao K; Zhang X; Zhang A; Guo S; Chen S; Meng Y; Deng M; Hao W; Lei H; Lin Y; Yang Z; Tang D; Wong KH; Zhang XD; Xu X; Deng CX
Theranostics; 2021; 11(20):9967-9987. PubMed ID: 34815798
[No Abstract] [Full Text] [Related]
14. BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.
Wang H; Bierie B; Li AG; Pathania S; Toomire K; Dimitrov SD; Liu B; Gelman R; Giobbie-Hurder A; Feunteun J; Polyak K; Livingston DM
Mol Cell; 2016 Jul; 63(2):277-292. PubMed ID: 27373334
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the BRCA1/long non-coding RNA NEAT1 signaling axis contributes to breast tumorigenesis.
Lo PK; Zhang Y; Wolfson B; Gernapudi R; Yao Y; Duru N; Zhou Q
Oncotarget; 2016 Oct; 7(40):65067-65089. PubMed ID: 27556296
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 Attenuates Progesterone Effects on Proliferation and NFκB Activation in Normal Human Mammary Epithelial Cells.
Hilton HN; Patterson McDonald LJ; Santucci N; van der Bent FR; Silvestri A; Graham JD; Clarke CL
J Mammary Gland Biol Neoplasia; 2019 Sep; 24(3):257-270. PubMed ID: 31104199
[TBL] [Abstract][Full Text] [Related]
17. Growth inhibition and activation of apoptotic gene expression by human chorionic gonadotropin in human breast epithelial cells.
Srivastava P; Russo J; Mgbonyebi OP; Russo IH
Anticancer Res; 1998; 18(6A):4003-10. PubMed ID: 9891438
[TBL] [Abstract][Full Text] [Related]
18. Wild-type BRCA1, but not mutated BRCA1, regulates the expression of the nuclear form of beta-catenin.
Li H; Sekine M; Tung N; Avraham HK
Mol Cancer Res; 2010 Mar; 8(3):407-20. PubMed ID: 20215423
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 suppresses osteopontin-mediated breast cancer.
El-Tanani MK; Campbell FC; Crowe P; Erwin P; Harkin DP; Pharoah P; Ponder B; Rudland PS
J Biol Chem; 2006 Sep; 281(36):26587-601. PubMed ID: 16807234
[TBL] [Abstract][Full Text] [Related]
20. Primary prevention of breast cancer by hormone-induced differentiation.
Russo IH; Russo J
Recent Results Cancer Res; 2007; 174():111-30. PubMed ID: 17302191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]